Grit enters the in vivo Car-T race
And Vironexis’s second gene therapy-encoded T-cell engager will soon go clinical.
Blood cancer gene therapies enter the clinic
First-in-human trial initiations feature Interius, Umoja and Vironexis.
And Vironexis’s second gene therapy-encoded T-cell engager will soon go clinical.
First-in-human trial initiations feature Interius, Umoja and Vironexis.
